Grifols

GAMASTAN

Manufacturer:

Grifols

Gamastan HCPCS:

J1460

HCPCS Code Descriptor:

Injection, gamma globulin, intramuscular, 1 cc

Category:

J Code

Gamastan NDCs:

13533-0335-04, 13533-0635-04, 13533-0635-12, 13533-0335-12

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intramuscular

Gamastan CPT Codes:

Potential CPT administration codes for Gamastan can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Gamastan:

GAMASTAN is an Immunoglobulin drug manufactured by Grifols and administered via the Intramuscular route of administration. The J Code: J1460 is aligned to the drug GAMASTAN.

GAMASTAN is a polyclonal antibody indicated to mitigate the effects of varicella and measles as well as rubella in women who will not or cannot obtain a therapeutic abortion. It is also commonly used to prevent measles and for prophylactic treatment after exposure to hepatitis A. GAMASTAN (J1460) works by increasing passive immunity in the body. It is most effective as a prophylactic agent when given right after exposure.

ACCESS PRICING AND MORE BY REGISTERING

J1460 Added Date:

January 1, 1984

J1460 Effective Date:

January 1, 2017

J1460 Termination Date:

HCPCS Active

Gamastan billing and coding information can be found through Grifols at the link below:
Our team did not identify a source for Gamastan patient assistance information. Please reach out to our team if you feel that this is a mistake.
GAMASTAN prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for GAMASTAN. Please check back in a few weeks.